Salvia BioElectronics develops bioelectronic solutions for migraine therapy and other neurological disorders. The company focuses on personalized migraine treatments using bioelectronic technology. Their device is not yet approved for commercial use.

Salvia BioElectronics

Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empower people with migraine to reclaim their lives. Our personalized migraine therapy is tailored to the needs of individual patients. And our ambition doesn’t stop there. With our unique bioelectronic technology, we are also exploring applications for other neurological disorders. Our unwavering commitment is driven by a deep desire to restore hope, health and happiness to people around the globe and to improve the overall well-being and quality of life for individuals and their families.

The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).

Today we celebrate that one year ago our first patient received our paper-thin implant. 🙏

As a pioneer in the field of medical devices, we are passionately committed to empowering people with migraine to reclaim their lives. ‍

Our unwavering commitment is driven by a deep desire to restore hope, health and happiness to people around the globe by improving the overall well-being and quality of life for individuals and their families.

More information: https://lnkd.in/ebDn_Pxc

𝘚𝘢𝘭𝘷𝘪𝘢 𝘉𝘪𝘰𝘌𝘭𝘦𝘤𝘵𝘳𝘰𝘯𝘪𝘤𝘴 𝘪𝘴 𝘤𝘶𝘳𝘳𝘦𝘯𝘵𝘭𝘺 𝘪𝘯 𝘵𝘩𝘦 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘴𝘵𝘢𝘨𝘦 𝘰𝘧 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵. 𝘚𝘢𝘭𝘷𝘪𝘢’𝘴 𝘥𝘦𝘷𝘪𝘤𝘦 𝘪𝘴 𝘯𝘰𝘵 𝘺𝘦𝘵 𝘢𝘱𝘱𝘳𝘰𝘷𝘦𝘥 𝘧𝘰𝘳 𝘤𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭 𝘶𝘴𝘦. 𝘞𝘦 𝘮𝘢𝘬𝘦 𝘯𝘰 𝘤𝘭𝘢𝘪𝘮𝘴 𝘢𝘣𝘰𝘶𝘵 𝘴𝘢𝘧𝘦𝘵𝘺 𝘰𝘳 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘯𝘦𝘴𝘴.

The Association of Migraine Disorders provides valuable insights into commonly used terms in the migraine community, highlighting their differences and meanings. Understanding these distinctions can empower patients and healthcare professionals to communicate more effectively and foster a supportive environment for those affected by migraine.

References: 
💡 Refractory vs. resistant migraine: https://lnkd.in/ghU8T-3Q
💡 Chronic migraine and status migrainosus:  International Classification for Headache Disorders (ICHD-3)

*Resistant and refractory migraine are not classified as migraine types in the International Classification for Headache Disorders (ICHD-3). However, they are terms commonly used in the migraine community.

Did you know that Salvia started with nothing more than innovative ideas and a blank whiteboard?

Salvia BioElectronics was founded on March 3, 2017 by Hubert Martens, Daniel Schobben and Wim Pollet. The founders (with extensive backgrounds in medical technology and neuromodulation) started their journey by understanding the needs of patients and healthcare professionals, building a team and conceptualizing the first shapes, characteristics and functionalities of a neuromodulation solution for people with migraine.

Now, we are a team of nearly 50 people, with the first patients in clinical trials in Europe and Australia. Read more on our website salviabioelectronics.com.

𝘛𝘩𝘪𝘴 𝘱𝘰𝘴𝘵 𝘤𝘰𝘯𝘵𝘢𝘪𝘯𝘴 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘢𝘣𝘰𝘶𝘵 𝘢 𝘥𝘦𝘷𝘪𝘤𝘦 𝘯𝘰𝘵 𝘺𝘦𝘵 𝘢𝘱𝘱𝘳𝘰𝘷𝘦𝘥 𝘧𝘰𝘳 𝘤𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭 𝘶𝘴𝘦. 𝘚𝘢𝘭𝘷𝘪𝘢 𝘉𝘪𝘰𝘌𝘭𝘦𝘤𝘵𝘳𝘰𝘯𝘪𝘤𝘴 𝘮𝘢𝘬𝘦𝘴 𝘯𝘰 𝘤𝘭𝘢𝘪𝘮𝘴 𝘢𝘣𝘰𝘶𝘵 𝘴𝘢𝘧𝘦𝘵𝘺 𝘰𝘳 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘯𝘦𝘴𝘴.

𝐅𝐚𝐜𝐞𝐬 𝐨𝐟 𝐒𝐚𝐥𝐯𝐢𝐚 - "My job is to make sure everything runs smoothly in the operation." - Meet Frank van Wijk, Operations Director at Salvia BioElectronics.

"As a child, I grew up with cars," says Frank. This passion led him to study Mechanical Engineering and Transport Technology at the Eindhoven University of Technology. It wasn't surprising that he did an internship at vehicle manufacturer DAF Trucks NV in Eindhoven. 

But it wasn’t his only passion. Frank's career took a significant turn when he switched to the medical device industry. Moving from large machines to the smallest of sophisticated devices, he spent the next 25 years at Medtronic. Starting as an R&D engineer, he eventually became Director/Site Leader for CardioVascular. He led a team of cleanroom engineers and operators, conducted studies and managed clinical products, including implantable devices for the heart, nerves and muscles. "When I started, Medtronic had 10,000 employees. By the time I left, it had grown to close to 100,000."

Frank then took on roles as VP of Operations and Director of Operations for several companies, including those that made catheters and pharmaceutical packaging. He found himself back in factories with huge machinery, reminiscent of his early days as a mechanical engineer. "At the pharmaceutical packaging company, we were like a bakery," he says. "There were 10-meters-high 'mixers’, 'ingredients' going in, forms being 'baked'- and at the end all packaged in very clean Class 5 cleanrooms."

This year, Frank began his new role as Operations Director at Salvia BioElectronics. "Our goal is to reliably deliver our innovation to patients currently in clinical trials. My focus is on in-house manufacturing, infrastructure and supply chain." Frank compares his time at Salvia to his early years at Medtronic. "Salvia feels like those early years at Medtronic, where you really get to know the company inside and out, working closely with the product, make a difference for the patient and help the organization to grow."

Reflecting on his journey, Frank says, "It's nice to look back on the kid who liked cars so much. If I could have imagined back then that I would have so much responsibility in developing products to help people, I would have been amazed. It makes me proud.”

𝘚𝘢𝘭𝘷𝘪𝘢’𝘴 𝘥𝘦𝘷𝘪𝘤𝘦 𝘪𝘴 𝘯𝘰𝘵 𝘺𝘦𝘵 𝘢𝘱𝘱𝘳𝘰𝘷𝘦𝘥 𝘧𝘰𝘳 𝘤𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭 𝘶𝘴𝘦. 𝘞𝘦 𝘮𝘢𝘬𝘦 𝘯𝘰 𝘤𝘭𝘢𝘪𝘮𝘴 𝘢𝘣𝘰𝘶𝘵 𝘴𝘢𝘧𝘦𝘵𝘺 𝘰𝘳 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘯𝘦𝘴𝘴.

This is why we love High Tech Campus Eindhoven, the place where we are located. What started with just one company 25 years ago, Philips, has grown into an international ecosystem of more than 300 innovative companies shaping the future. 🚀 To mark this incredible milestone, some of our Salvia colleagues joined the longest picnic we've ever seen! 🎉

#HighTechCampus #Innovation #Anniversary

As Salvia, we are excited to be part of the Patch Foundry project, working together with Traxcon BV, Holst Centre, Elitac Wearables BV and Brabant Development Agency (BOM) on new flexible and wearable device technologies that form the basis of novel ‘skin patches’ for novel health and wellness therapies. 

Learn more about this project on our website: https://lnkd.in/eD5H4uiK

Metric
Company Name	Salvia BioElectronics
Symbol
MSH ID	COM:SALVIABIOELECTRONICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	NL
Stage
Employee Count	44
Website	salviabioelectronics.com
LinkedIn	salviabioelectronics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SALVIABIOELECTRONICS

Salvia BioElectronics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue